symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
TELA,6.015,0.978825,99801,147292313,0,5.99-13.18,-0.155,"TELA Bio, Inc.",USD,0001561921,US8723811084,872381108,NASDAQ Global Market,NASDAQ,Medical Devices,https://www.telabio.com,"TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. The company markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.",Mr. Antony  Koblish,Healthcare,US,173,484 320 2930,1 Great Valley Parkway,Malvern,PA,19355,0.523559,11.2564,https://financialmodelingprep.com/image-stock/TELA.png,2019-11-08,False,False,True,False,False
